Enjoy a 15% discount when you use the code EQLYSEPT24 at checkout from the 17th to the 30th of September 2024

Carl Quash III

Carl Quash III Industry Manager - Food & Nutrition

chicago

English

About Carl

Carl is Euromonitor International’s Industry Manager for packaged food, covering snacks and nutrition research. He oversees research on snacks and analysis in 100 national markets worldwide.

Follow:

Expertise

Carl provides thought leadership and advises clients on how key trends in snacks and changing consumer behaviour will impact business operations. He specialises in trend discovery, innovation and snack product development. Carl has worked in the food space for more than a decade. Prior to his career at Euromonitor, Carl was a food formulation scientist working on enzyme processing aids, snack bars, and processed pasteurised cheese products. He has supported clients in nutrition labelling, formula design, and go-to market strategy.

Recently Published Work

Article

Five Key Snack Trends to Track in 2024-2025

Carl Quash III

Carl Quash III

23 Aug 24

Global snack sales continue to grow – set to surpass USD680 billion in retail sales in 2024, up 5.6% from 2023. Though inflation is slowing and promotions are peaking, challenges such as the cocoa crisis and consumers’ reassessment of their snack spend persist. Euromonitor International’s snacks research has identified five key trends set to shape snacks in the year ahead.

Article

The Future of Positive Nutrition and Challenges to Overcome

Carl Quash III

Carl Quash III

28 May 24

Consumers’ relationship with diets is ever-changing. Now, unprecedented priority is being placed on addressing diet-related human health issues to improve what and how we eat and build a future containing a healthy, productive population. World Nutrition Day is a time to reflect on the greatest challenges that positive nutrition faces and what can be done to overcome them.

Article

What Could Weight Loss Drugs Mean for Food and Beverage?

Carl Quash III

Carl Quash III

20 Nov 23

Ozempic and Wegovy, weight loss drugs, have received lots of buzz lately as new challengers to the global obesity epidemic. With abilities to suppress appetite, the food industry is concerned about what this means for sales. Future adoption of these drugs is set to increase, as are sales of broader weight management-claimed food and beverages. And even with many unknowns, our experts believe strong worry about negative, long-term impact should be moderated and brands should take certain actions.

;